These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19862688)

  • 1. Alterations in 5-HT2A receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats.
    Li Y; Huang XF; Deng C; Meyer B; Wu A; Yu Y; Ying W; Yang GY; Yenari MA; Wang Q
    Synapse; 2010 Mar; 64(3):224-30. PubMed ID: 19862688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of NMDA receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats.
    Wang Q; Li J; Wei X; Liao J; Xu Y; Lu T; Qin B; Xie J; Deng C; Huang X
    Int J Neurosci; 2014 Jun; 124(6):457-65. PubMed ID: 24102195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats.
    Liu CQ; Chen Z; Liu FX; Hu DN; Luo JH
    Neuropharmacology; 2007 Dec; 53(7):832-41. PubMed ID: 17919665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased 5-HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations.
    Huot P; Johnston TH; Darr T; Hazrati LN; Visanji NP; Pires D; Brotchie JM; Fox SH
    Mov Disord; 2010 Jul; 25(10):1399-408. PubMed ID: 20629135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of behavioural effects of a selective NMDA NR1A/2B receptor antagonist in the unilateral 6-OHDA lesion rat model.
    Warraich ST; Allbutt HN; Billing R; Radford J; Coster MJ; Kassiou M; Henderson JM
    Brain Res Bull; 2009 Feb; 78(2-3):85-90. PubMed ID: 18822357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family history of alcoholism is associated with lower 5-HT2A receptor binding in the prefrontal cortex.
    Underwood MD; Mann JJ; Huang YY; Arango V
    Alcohol Clin Exp Res; 2008 Apr; 32(4):593-9. PubMed ID: 18241316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
    J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic treatment with clozapine and haloperidol on 5-HT(2A and 2C) receptor mRNA expression in the rat brain.
    Huang XF; Tan YY; Huang X; Wang Q
    Neurosci Res; 2007 Nov; 59(3):314-21. PubMed ID: 17868938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estradiol modulation of cortical, striatal and raphe nucleus 5-HT1A and 5-HT2A receptors of female hemiparkinsonian monkeys after long-term ovariectomy.
    Sánchez MG; Estrada-Camarena E; Bélanger N; Morissette M; Di Paolo T
    Neuropharmacology; 2011 Mar; 60(4):642-52. PubMed ID: 21144854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes on 5-HT2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson's disease model.
    Zhang X; Andren PE; Svenningsson P
    Physiol Behav; 2007 Sep; 92(1-2):29-33. PubMed ID: 17588622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic buspirone treatment decreases 5-HT1B receptor densities and the serotonin transporter but increases the density of 5-HT2A receptors in the bulbectomized rat model of depression: an autoradiographic study.
    Sato H; Skelin I; Diksic M
    Brain Res; 2010 Jul; 1345():28-44. PubMed ID: 20501324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptors.
    Steward LJ; Kennedy MD; Morris BJ; Pratt JA
    Neuropharmacology; 2004 Sep; 47(4):527-37. PubMed ID: 15380371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 1. Dopaminergic neurons and receptors.
    Yokoyama C; Okamura H
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1016-30. PubMed ID: 9023319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson's Disease: implications for limbic system and basal ganglia interactions.
    Turner MS; Gray TS; Mickiewicz AL; Napier TC
    Brain Struct Funct; 2008 Sep; 213(1-2):197-213. PubMed ID: 18663473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acupuncture on 6-hydroxydopamine-induced nigrostratal dopaminergic neuronal cell death in rats.
    Kim YK; Lim HH; Song YK; Lee HH; Lim S; Han SM; Kim CJ
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):133-8. PubMed ID: 15893426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT(2A) receptors.
    Shen FM; Wang J; Ni CR; Yu JG; Wang WZ; Su DF
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):702-7. PubMed ID: 17600544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain.
    Sumner BE; Grant KE; Rosie R; Hegele-Hartung Ch; Fritzemeier KH; Fink G
    Neurosci Lett; 2007 Apr; 417(1):95-9. PubMed ID: 17398000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ketanserin and amphetamine on nigrostriatal neurotransmission and reactive oxygen species in Parkinsonian rats. In vivo microdialysis study.
    Nowak P; Szczerbak G; Biedka I; Drosik M; Kostrzewa RM; Brus R
    J Physiol Pharmacol; 2006 Dec; 57(4):583-97. PubMed ID: 17229983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density.
    Lian J; Huang XF; Pai N; Deng C
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():62-8. PubMed ID: 23994047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.